[Skip to Content]
[Skip to Content Landing]
January 8, 1949


JAMA. 1949;139(2):82-86. doi:10.1001/jama.1949.02900190012004

The management of ocular hypertension associated with iridocyclitis constitutes one of the most difficult problems in ophthalmology. The accepted dogma is to consider the condition in all such cases as secondary glaucoma and to adopt a more or less standard formula for treatment. Yet, when confronted with a case of iridocyclitis in which ocular hypertension develops, the physician wonders whether to continue with a mydriatic, change to a miotic or resort to surgical treatment. On the other hand, there are instances in which fairly successful miotic treatment was discontinued in favor of treatment with mydriatics, because a few keratic precipitates or cells in the aqueous were discovered.

The vagueness in the approach to this problem is due largely to the manner in which cases of secondary glaucoma have been classified. Of course, the ideal classification would be an etiologic one. There have been occasional reports of cases in which the